However, both the “CTLA-4 signaling in Cytotoxic T-lymphocytes” and the “PD-1, PD-L1 cancer immunotherapy” pathways appear paradoxically inactivated during csACR; the negative z-scores indicate downstream messaging and effector proteins are not inhibited as would be expected. The gene discussed is CTLA4; the disease is cancer.